Skip to main content
Premium Trial:

Request an Annual Quote

SomaLogic to Conduct Aptamer Feasibility Study with Beckman Coulter

NEW YORK, July 23 - SomaLogic said today it has signed an agreement with Beckman Coulter to conduct a feasibility study on the integration of its aptamer technology with Beckman Coulter's liquid handling workstation and plate and array reader platforms.

 

Under the agreement, SomaLogic, of Boulder, Colo., will work with Beckman Coulter's Advanced Technology Center, which evaluates technologies as to their usefulness in future products.

 

"We are pleased to be working together to develop new approaches for array-based quantitative proteomics," stated Keith Warner SomaLogic's chief business officer. "We look forward to the possibility of creating next- generation products that combine our aptamers with Beckman Coulter's industry- leading fluid handling systems and innovative array technologies."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.